EcoR1 Capital, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$7,284,000
-5.8%
5,603,191
+149.9%
0.73%
+4.6%
Q3 2018$7,735,000
-61.7%
2,241,900
-49.5%
0.70%
-63.7%
Q2 2018$20,191,000
+40.0%
4,437,6000.0%1.92%
+32.8%
Q1 2018$14,422,000
+3.8%
4,437,600
+24.6%
1.45%
-7.5%
Q4 2017$13,894,0003,562,6001.56%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders